Why don't you sell it for Rs.5?

As India plays host to the Convention on Biological Diversity's 11th Conference of the Parties in Hyderabad in October 2012, this article takes a closer look at the country's legislation on the subject - the Biological Diversity Act (2002).

Open source drug discovery offers potential for developing new and inexpensive drugs to combat diseases that disproportionally affect the poor. The concept borrows two principle aspects from open source computing (i.e., collaboration and open access) and applies them to pharmaceutical innovation. By opening a project to external contributors, its research capacity may increase significantly. To date there are only a handful of open source R&D projects focusing on neglected diseases.

14 New Drug Molecules Approved Between Jan & July 2012, Only 9 Tested: Azad

Novartis patent case up for hearing this week; judgment to have far-reaching impact

An inter-ministerial group tasked with regulating prices of patented medicines has recommended using a per capita income-linked reference pricing mechanism, a proposal that may reduce prices of sev

Upcoming patent expiries stand to make medicines cheaper — although less convenient.

The traditional knowledge (TK) of India’s people touches many lives within the country and outside it. For the holders of TK, it is their very lives and thus valuable as is.

Uncontrolled medical treatment in Asia and Africa costs lives and money. David Peters and Gerald Bloom call for governments, firms and citizen groups to get involved.

The National Institute for Inter-disciplinary Science and Technology (NIIST) is offering a technology for clear extraction of banana fibre on a non-exclusive basis.